| European Case Law Identifier: | ECLI:EP:BA:2016:T045415.20160725 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 25 July 2016 | ||||||||
| Case number: | T 0454/15 | ||||||||
| Application number: | 06027055.0 | ||||||||
| IPC class: | A61K 38/29 A61P 19/08 A61K 33/06 A61K 31/59 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | hPTH(1-34) for use in preventing or reducing the incidence or severity of vertebral and / or non vertebral fracture in a male human | ||||||||
| Applicant name: | Eli Lilly and Company | ||||||||
| Opponent name: | Zentiva k.s. STADA Arzneimittel AG Teva Pharmaceutical Industries Ltd. |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Withdrawal of approval of text on which patent was granted - appeal dismissed | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t150454eu1.html
Date retrieved: 17 May 2021